| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA758: Solriamfetol for treating excessive waketime sleepiness caused by narcolepsy |
|
Medicine details |
|
| Medicine name | solriamfetol (Sunosi®) |
| Formulation | 75 mg, 150 mg film-coated tablet |
| Reference number | 4436 |
| Indication | To improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy (with or without cataplexy) |
| Company | Jazz Pharmaceuticals plc |
| BNF chapter | Central nervous system |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 22/01/2020 |
| NICE guidance | TA758: Solriamfetol for treating excessive waketime sleepiness caused by narcolepsy |